Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Also in the quarter, we initiated a new position in manufacturer and developer of laboratory equipment and biological testing, Bio-Rad Laboratories Inc. (BIO). The company offers...
— Ariel Investments, LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories ($BIO) develops, manufactures, and markets clinical diagnostics instruments and life sciences laboratory research systems, constituting 4.6% of the fund. The manager takes...
Bio-Rad Laboratories ($BIO), accounting for 3.0% of the strategy's assets, is a global life sciences instrumentation and clinical diagnostics equipment provider. The manager maintains...
Bio-Rad Laboratories ($BIO) is a life sciences and clinical diagnostics manufacturer that produces lab instruments, reagents, and test kits, while holding a non-consolidated 32% ownership stake in Sartorius AG. The manager initiated...
More institutional theses from Ariel Small Cap Value Strategy
Charles River Laboratories International, Inc. ($CRL), representing 3.4% of the composite, provides early-stage contract research services, animal models, and clinical discovery support for global pharmaceutical and biotechnology corporations. Ariel maintains a...
Zebra Technologies Corporation ($ZBRA), which accounts for 4.1% of the representative portfolio, is a global leader in enterprise asset intelligence, manufacturing barcode scanners, RFID readers, mobile computers, and workflow automation hardware. The strategy remains...
ADI Global Distribution, Inc. ($ADIG) represents 0.7% of the portfolio and was added as a new holding during the quarter following its corporate spin-off from Resideo Technologies. The company is...